UnicoCell Biomed Co., Ltd. (6794.TW)

TWD 70.8

(0.28%)

Total Liabilities Summary of UnicoCell Biomed Co., Ltd.

  • UnicoCell Biomed Co., Ltd.'s latest annual total liabilities in 2023 was 89.48 Million TWD , up 11.22% from previous year.
  • UnicoCell Biomed Co., Ltd.'s latest quarterly total liabilities in 2024 Q2 was 90.89 Million TWD , up 0.9% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported annual total liabilities of 80.45 Million TWD in 2022, up 131.81% from previous year.
  • UnicoCell Biomed Co., Ltd. reported annual total liabilities of 34.7 Million TWD in 2021, down -27.41% from previous year.
  • UnicoCell Biomed Co., Ltd. reported quarterly total liabilities of 90.08 Million TWD for 2024 Q1, up 0.67% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported quarterly total liabilities of 92.66 Million TWD for 2023 Q2, up 127.76% from previous quarter.

Annual Total Liabilities Chart of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Historical Annual Total Liabilities of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 89.48 Million TWD 11.22%
2022 80.45 Million TWD 131.81%
2021 34.7 Million TWD -27.41%
2020 47.81 Million TWD 0.0%
2019 - TWD 0.0%

Peer Total Liabilities Comparison of UnicoCell Biomed Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Apex Biotechnology Corp. 500.07 Million TWD 82.105%
Sinphar Pharmaceutical Co.,Ltd. 2.85 Billion TWD 96.864%
Panion & Bf Biotech Inc. 1.32 Billion TWD 93.242%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 1.82 Billion TWD 95.087%
GenMont Biotech Incorporation 204.05 Million TWD 56.147%
Abnova (Taiwan) Corporation 69.42 Million TWD -28.899%
Adimmune Corporation 3.7 Billion TWD 97.586%
Tanvex BioPharma, Inc. 1.94 Billion TWD 95.393%
Polaris Group 1.46 Billion TWD 93.891%
Energenesis Biomedical CO.,LTD. 24.58 Million TWD -263.961%
PELL Bio-Med Technology Co. Ltd. 236.76 Million TWD 62.204%